Accelerated Immunodeficiency-associated Vaccine-derived Poliovirus Serotype 3 Sequence Evolution Rate in an 11-week-old Boy With X-linked Agammaglobulinemia and Perinatal Human Immunodeficiency Virus Exposure

Clin Infect Dis. 2020 Jan 1;70(1):132-135. doi: 10.1093/cid/ciz361.

Abstract

Primary B-cell immunodeficiencies are risk factors for the generation of vaccine-derived polioviruses. We report immunodeficiency-associated vaccine-derived poliovirus serotype 3 in an 11-week-old boy with X-linked agammaglobulinemia. Unique characteristics of this case include early age of presentation, high viral evolutionary rate, and the child's perinatal exposure to human immunodeficiency virus.

Keywords: Bruton tyrosine kinase; HIV-exposed but uninfected; X-linked agammaglobulinemia; acute flaccid paralysis; oral poliovirus vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinemia*
  • Child
  • Genetic Diseases, X-Linked
  • HIV / genetics
  • Humans
  • Male
  • Poliomyelitis*
  • Poliovirus Vaccine, Oral / adverse effects
  • Poliovirus* / genetics
  • Serogroup

Substances

  • Poliovirus Vaccine, Oral

Supplementary concepts

  • Bruton type agammaglobulinemia